We are thrilled to announce that our Executive Chairman, Mike Cohen, and our CEO, James Lovett, have been named EY's "Entrepreneurs of The Year 2024" for the Greater Philadelphia Region! 🎉 This prestigious award, founded in 1986, honors visionary leaders who drive dynamic businesses with ingenuity, courage, and entrepreneurial spirit. Among 30 finalists, Mike and James stood out and were celebrated at the recent awards gala in Philadelphia. This recognition is not just an individual achievement for Mike and James but a testament to our entire team's hard work and dedication. It reflects the combined efforts and commitment of everyone at Myonex to drive our mission forward every day. Congratulations, Mike and James, and thank you to our entire Myonex team, including our colleagues at Creapharm, a Myonex company, and Saveway Compounding Pharmacy, a Myonex company, for making this possible! Read the full story here: https://bit.ly/3V6DSW8 #Myonex #EntreprenueroftheYear #LifeSciences #Pharmaceuticals #ClinicalTrials #ClinicalTrialSupply #Leadership #Innovation
Myonex
Pharmaceutical Manufacturing
Horsham, Pennsylvania 13,510 followers
Your Clinical Trial Supply Partner
About us
Whether your health product is still in research, entering a clinical trial, or ready to be marketed, Myonex is a total global partner committed to assisting and supporting a wide range of projects with supply and services from clinical to commercial. With ten locations in the US, Germany, UK & France, we partner with pharmaceutical and biotechnology companies, contract research organizations (CROs), hospitals, and sites seeking a flexible, comprehensive solution for their project needs. Learn more at www.myonex.com Clinical Services Include: Primary and secondary packaging and labeling Drug sourcing CTRx ™ Ancillaries Storage and distribution QP oversight Biological sample management and ATMPs supply chain Managed access Decentralized Clinical Trials and Direct-to-Patient services Compounding Commercial Services Include: Primary and secondary packaging and labeling ATMPs supply chain Serialization and aggregation Rx, OTC & food supplements
- Website
-
http://www.myonex.com
External link for Myonex
- Industry
- Pharmaceutical Manufacturing
- Company size
- 201-500 employees
- Headquarters
- Horsham, Pennsylvania
- Type
- Privately Held
- Founded
- 1987
- Specialties
- Access to restricted/hard-to-find drugs, in-depth knowledge of global markets, product labeling, distribution, and management, international logistics expertise, recall monitoring and lot traceability, secure GMP facilities, and sourcing for biosimilar research.
Locations
-
Primary
100 Progress Dr
Horsham, Pennsylvania 19044, US
-
1 Meer End
Birstall
Leicester, Leicestershire LE4 3EH, GB
-
Alhambra House Alhambravej 3 1826
Frederiksberg, DK
Employees at Myonex
Updates
-
Myonex reposted this
Great yesterday to meet M. Arnaud Robinet, Mayor of Reims, France, and his team, along with Eric Placet, founder of Creapharm and our newest Board Member at Myonex. Happy to be growing Myonex in Reims. #Myonex #Reims #clinicaltrialsupply #pharmapackaging #Creapharm #chooseFrance
🇨🇵 #ChooseFrance #ChooseReimsLégendR 🌍 🌟 #Reims et le #GrandEst s'illustrent comme une destination privilégiée pour les investissements internationaux alors que le sommet "Choose France" annonce un record de 15 milliards d'euros d'investissements dont plusieurs milliards en Région Grand Est. ✔ Le groupe rémois #Creapharm a récemment conclu un accord avec #Myonex, l'un des leaders mondiaux de l’approvisionnement des essais cliniques, pour qu'il puisse acquérir les activités de #conditionnement et distribution cliniques, de conditionnement commercial ainsi que les #bioservices" de l'entreprise rémoise donnant naissance a Creapharm, a Myonex company. 🏭 Cette collaboration témoigne de la dynamique économique du territoire de Reims et de son engagement dans les secteurs clés de l' #innovation tels que la #santé et des #Biotechnologies. 💊🌱 🤝 Arnaud Robinet, président de la Communauté urbaine du Grand Reims a pu rencontrer James Lovett, Directeur Général de Myonex et Eric Placet fondateur de #Creapharm, en compagnie d'une délégation #ReimsBusines afin d'évoquer le développement des partenariats solides entre les entreprises locales et internationales, façonnant l'avenir économique de notre région. 💪 👉 #ReimsLégendR, votre prochaine destination d'#investissement ! 👍 Choose Reims LégendR pour votre expansion internationale. 📈 ➕️ www.reimsbusiness.fr 👇 English version below in comment 👇 #ReimsVisionR #ReimsExemplR #TousLégendR Présidence de la République | Ministère de l’Économie, des Finances et de la Souveraineté industrielle et numérique | Business France | Invest Eastern France | Bpifrance | Les CCE _ Choose France | | Ville de Reims || Edouard Placet | Carla Da Costa | Sophie Lafon Rouquier | Patricia Durin-Lesenne | Jean Claude Desloques | Laurent Vercruysse | olivier Martin | Simon Cossiez | Pierre-Antoine HUET-DUFOUR
-
Did you miss Benedict Hirth’s “Is Clinical Supply the Weakest Link in Your Chain” presentation at Clinical Outsourcing Group New England? You’ve got an opportunity to catch his presentation as a webinar! Understand the significant risks and consequences of a poorly managed clinical supply chain. Mitigate risks through proactive supply chain management strategies and how to identify potential risks ahead of time. 📅 Date: Thursday, May 23, 2024 ⏰ Time: 11 AM EDT (NA) / 4 PM BST (UK) / 5 PM CEST (EU-Central) 👉 Register now at: https://bit.ly/4dK4vcj #ClinicalTrials #ClinicalTrialSupply #Webinar #Myonex #COGNE
🚀 Join Myonex for an upcoming webinar on clinical supply chain management! Explore the challenges faced by the clinical supply chain, from navigating complex trial designs to ensuring sustainability and cost control! The expert speaker, Benedict Hirth, will illuminate the risks associated with a poorly managed clinical supply chain, such as delayed drug availability, aggressive enrollment targets, and potential commercialization delays. Learn how drug shortages can impact reputation, burden patients, and affect treatment efficacy and retention, including insights into proactive strategies for risk identification, market observation, and scenario preparedness. 💡 REGISTER HERE: https://buff.ly/3Wq49Bj
-
We're proud to share that James Lovett, Myonex CEO, has been nominated for the Life Sciences & Healthcare CEO category at the 2024 Philadelphia Alliance for Capital and Technologies (PACT) Awards. Starting as a small team in Norristown, PA, Myonex has grown into a global leader with over 400 employees. This growth has been fueled by our unwavering commitment to partnering with our clients to enhance their clinical trials and patient care worldwide. Our recent expansions, including the acquisitions of Creapharm, a Myonex company, and Saveway Compounding Pharmacy, a Myonex company, highlight our continued dedication to being the fastest, most flexible and reliable partner in the clinical trial industry. We’re excited to celebrate this milestone—join us at the awards ceremony on May 21st! RSVP here: https://bit.ly/4d9I67R. #PACTAwards #HealthcareLeadership #Myonex #Innovation #ClinicalTrials #ClinicalTrialSupply
🏆 EA Finalist Spotlight: James Lovett, CEO of Myonex, is nominated in the Life Sciences & Healthcare CEO category at the 2024 Awards. Discover their impactful work: https://bit.ly/3WjUegF Be part of the celebration! RSVP for the awards ceremony and networking event on 5/21 here: https://bit.ly/4d9I67R
2024 Enterprise Awards
philadelphiapact.com
-
Enjoying Global Clinical Supplies Group - GCSG with some of our future team members from CREAPHARM BIO&PHARMA* at booths 14 and 15! We're discussing the benefits of expanded services across clinical trial supply (including our exclusive solution CTRx) and our newest pharmacy acquisition, Saveway Compounding Pharmacy, a Myonex company. Stop by the booth now or contact a team member to talk through your project needs and see where our services can support you. *The completion of the acquisition is subject to regulatory approvals.
🇺🇸 Gathered with the Myonex’s team at GCSG US today. 📣 Have you already heard about the agreement we reached with Myonex for the acquisition* of the CREAPHARM’s pharmaceutical businesses? ⬆️ Looking forward to expand capabilities and global footprint. 🌍 Stay tuned! * The completion of the acquisition is subject to regulatory approvals.
-
Myonex reposted this
💎 The same services you’ve come to know and so much more with the recent announcement of reaching an agreement* with Myonex to acquire CREAPHARM GROUP's clinical & commercial packaging and bioservices business. 👇 Take a look at the carousel for what this looks like for clients. With strong assets 🔹 Continuous improvement: making the most of both organizations and continuing to strive for excellence, 🔹 Further investments to better support your growing needs, 🔹 Opportunities to bundle your services – eliminating multiple vendors, streamlining management, and providing you a time and cost savings. * The completion of this transaction is subject to regulatory approvals
-
Myonex reposted this
🏆 Ensuring the #success of our #clients’ clinical trials and #patients was a driving factor in reaching an agreement* for the #acquisition by Myonex of the CREAPHARM GROUP’s clinical packaging & distribution and commercial packaging business and bioservices. * The completion of this transaction is subject to regulatory approvals 👉 See what Mike Cohen, Myonex Co-owner and Executive Chairman, had to say, in the Press Release (link in first comment)
-
With our recent announcement of our agreement to acquire CREAPHARM BIO&PHARMA’s clinical packaging & distribution and commercial packaging business and bioservices, comes expanded packaging solutions for your projects: ☑️ ATMPs Supply Chain Management: Expert handling of biotherapies, ensuring integrity from storage to distribution. ☑️ Global Reach, Local Touch: With an extended global presence, we're bringing you closer to your markets while maintaining that personalized service you love. ☑️ Streamlined Efficiency: Bundle your packaging needs with Myonex’s other services for a smoother, more cost-effective process. Let's discuss how our new combined capabilities can elevate your next project’s clinical trial supply: https://bit.ly/48TKOuL The completion of this transaction is subject to regulatory approvals. #Myonex #PackagingExcellence #Innovation #ClinicalTrialsPackaging #Clinical Trials #ContractPackaging
Expanding Packaging Capabilities on a Global Scale
https://www.myonex.com
-
Myonex reposted this
Last week we were thrilled to announce CREAPHARM GROUP reached an #agreement with Myonex to acquire its clinical & commercial packaging and bioservices business*. What does it really mean? 🎯 Better together in #scale and #capabilities while keeping #flexibility to support each customer’s project 🎯 Enhanced global service #offerings: take a look at what’s coming up for your Clinical Trial Supply Management #CTSM ✔ A genuine comparator drug sourcing service ✔ Ancillary equipment and supplies ✔ QP oversight (UK) & IOR services, facilitating your UK clinical trials ✔ Additional clinical distribution pathways to serve your global clinical supply chain ✔ CTRx™, a combination of prescription card services, global pharmacy dispensing, and centralized local drug supply in a single solution 🎯 And obviously, still serving your clinical packaging and labelling needs, delivering a high-level pharmaceutical support, handling your commercial packaging operations and managing your ATMPs Supply Chain . * The completion of this transaction is subject to regulatory approvals 👇 See what Myonex CEO, James Lovett, had to say about...
-
Last week, we were thrilled to announce that Myonex entered into an agreement to acquire CREAPHARM BIO&PHARMA’s clinical packaging & distribution and commercial packaging businesses. This strategic move will combine our expertise in clinical trial supply with Creapharm's clinical trials and enhanced packaging and distribution capabilities, providing innovative, global solutions for the industry. Together, we aim to enhance our service offerings and better support our clients' evolving needs through faster, more flexible, and reliable services. 🔎 Read more about how our services and capabilities are expanding here: https://bit.ly/48TKOuL The completion of this transaction is subject to regulatory approvals. #ClinicalTrials #ClinicalTrialSupply #MergersandAcquisition #ClinicalTrialPackaging
Myonex to Acquire Parts of Creapharm Group
https://www.myonex.com